Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mukogawa Women's University | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
This prospective cohort study aims to identify risk factors for postoperative adverse events in liver transplant recipients and living donors. By collecting comprehensive clinical data and conducting systematic long-term follow-up, the researchers intend to establish a specialized, standardized, and individualized follow-up management system. The ultimate goal is to optimize intervention strategies and improve patient prognosis and quality of life for both recipients and donors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| recipients | A patient who received a new, healthy liver (or part of one from a living donor) to replace their own diseased liver |
| |
| living donors | A healthy person who donated a portion of their healthy liver to someone with liver failure. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| liver transplantation | Procedure | Patients undergo standard liver transplantation according to clinical protocols. Postoperative management and follow-up are conducted per routine standard of care. Clinical data, including survival, adverse events, and quality of life (assessed by questionnaires/scales), are collected observationally at regular follow-up intervals. |
| Measure | Description | Time Frame |
|---|---|---|
| Long-term Incidence of Postoperative Adverse Events | Evaluation of the cumulative incidence of postoperative complications | From date of surgery up to 20 years |
| Measure | Description | Time Frame |
|---|---|---|
| Overall Survival | Up to 20 years | |
| Graft Survival Rate | Up to 20 years | |
| Patient-Reported Outcome questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population comprises all consecutive patients with end-stage liver disease or acute liver failure scheduled for liver transplantation (recipients) and healthy individuals undergoing living donor hepatectomy (donors) at the Department of Liver Surgery of the study center. Participants are selected from the clinical practice setting of the study center.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Wen Fang | Contact | 19705094680 | wenfang@zju.edu.cn |
| Name | Affiliation | Role |
|---|---|---|
| Wen Fang | Second Affiliated Hospital, School of Medicine, Zhejiang University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Second Affiliated Hospital Zhejiang University School of Medicine | Recruiting | Hangzhou | Zhejiang | 310009 | China |
Not provided
Not provided
Not provided
Not provided
|
| Living Donor Hepatectomy | Procedure | Living donors undergo standard hepatectomy procedures. Postoperative recovery and long-term health outcomes are monitored through routine follow-up visits and assessments. |
|
Assessment of multiple dimensions of patient health status, including physical functioning, mental health, social well-being, symptoms burden (e.g., pain, fatigue), and medication adherence. These domains will be evaluated using a battery of standard validated instruments |
| Baseline and annually up to 20 years |
| ID | Term |
|---|---|
| D016031 | Liver Transplantation |
| ID | Term |
|---|---|
| D016378 | Tissue Transplantation |
| D064987 | Cell- and Tissue-Based Therapy |
| D001691 | Biological Therapy |
| D013812 | Therapeutics |
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
| D016377 | Organ Transplantation |
| D014180 | Transplantation |
Not provided
Not provided